NO991581L - N- (benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and use in therapeutic agents - Google Patents
N- (benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and use in therapeutic agentsInfo
- Publication number
- NO991581L NO991581L NO991581A NO991581A NO991581L NO 991581 L NO991581 L NO 991581L NO 991581 A NO991581 A NO 991581A NO 991581 A NO991581 A NO 991581A NO 991581 L NO991581 L NO 991581L
- Authority
- NO
- Norway
- Prior art keywords
- benzothiazol
- piperidine
- preparation
- therapeutic agents
- ethanamine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Forbindelser med den generelle formel (I). hvor n representerer tallet 0, 1, 2 eller 3, Rx representerer et hydrogen- eller halogenatom eller en metyl- eller metoksy-gruppe, Rrepresenterer et hydrogenatom eller en metylgruppe og Rrepresenterer et hydrogenatom eller et eller to. halogenatomer. Forbindelsene er anvendbare i terapi.Compounds of general formula (I). where n represents the number 0, 1, 2 or 3, Rx represents a hydrogen or halogen atom or a methyl or methoxy group, R represents a hydrogen atom or a methyl group and R represents a hydrogen atom or one or two. halogen atoms. The compounds are useful in therapy.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9611925A FR2753970B1 (en) | 1996-10-01 | 1996-10-01 | N- (BENZOTHIAZOL-2-YL) PIPERIDINE-1-ETHANAMINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| PCT/FR1997/001692 WO1998014444A1 (en) | 1996-10-01 | 1997-09-26 | N-(benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and application in therapeutics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO991581D0 NO991581D0 (en) | 1999-03-30 |
| NO991581L true NO991581L (en) | 1999-06-01 |
Family
ID=9496217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO991581A NO991581L (en) | 1996-10-01 | 1999-03-30 | N- (benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and use in therapeutic agents |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0929550A1 (en) |
| JP (1) | JP2001501217A (en) |
| KR (1) | KR20000048767A (en) |
| CN (1) | CN1230959A (en) |
| AR (1) | AR009105A1 (en) |
| AU (1) | AU722147B2 (en) |
| BG (1) | BG103271A (en) |
| BR (1) | BR9711842A (en) |
| CA (1) | CA2266510A1 (en) |
| CO (1) | CO4650030A1 (en) |
| CZ (1) | CZ112699A3 (en) |
| EE (1) | EE9900135A (en) |
| FR (1) | FR2753970B1 (en) |
| HU (1) | HUP9904091A3 (en) |
| IL (1) | IL128902A (en) |
| NO (1) | NO991581L (en) |
| NZ (1) | NZ334553A (en) |
| PL (1) | PL332648A1 (en) |
| SK (1) | SK42299A3 (en) |
| TR (1) | TR199900634T2 (en) |
| TW (1) | TW438800B (en) |
| WO (1) | WO1998014444A1 (en) |
| ZA (1) | ZA978772B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9725541D0 (en) * | 1997-12-02 | 1998-02-04 | Pharmacia & Upjohn Spa | Amino-benzothiazole derivatives |
| US6107313A (en) * | 1998-10-02 | 2000-08-22 | Combichem, Inc. | Dopamine receptor antagonists |
| KR100571161B1 (en) | 2000-06-21 | 2006-04-17 | 에프. 호프만-라 로슈 아게 | Benzothiazole derivatives |
| US7087761B2 (en) | 2003-01-07 | 2006-08-08 | Hoffmann-La Roche Inc. | Cyclization process for substituted benzothiazole derivatives |
| KR20060061393A (en) * | 2003-10-24 | 2006-06-07 | 에프. 호프만-라 로슈 아게 | Ccr3 receptor antagonists |
| PL1753760T3 (en) | 2004-05-24 | 2008-06-30 | Hoffmann La Roche | 4-hydroxy-4-methyl-piperidine-1-carboxylic acid (4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide |
| CA2586931C (en) | 2004-11-05 | 2013-08-06 | Paul Spurr | Process for preparation of isonicotinic acid derivatives |
| BRPI0609719B8 (en) | 2005-03-23 | 2021-05-25 | Hoffmann La Roche | acetylenyl-pyrazole-pyrimidine derivatives as mgbur2 antagonists |
| BRPI0616571A2 (en) | 2005-09-27 | 2011-06-21 | Hoffmann La Roche | oxadiazolyl pyrazol pyridimines as mglur2 antagonists, process for their preparation, pharmaceutical composition containing them and use thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1260474A (en) * | 1984-12-03 | 1989-09-26 | Raymond A. Stokbroekx | Benzoxazol- and benzothiazolamine derivatives |
| KR930005004B1 (en) * | 1985-04-15 | 1993-06-11 | 쟈안센 파아마슈우티카 엔. 부이. | Process for preparing substituted n-|(4-piperidinyl) alkyl¨ bicycle condensed oxazole and thiazolamines |
-
1996
- 1996-10-01 FR FR9611925A patent/FR2753970B1/en not_active Expired - Fee Related
-
1997
- 1997-09-26 KR KR1019990702753A patent/KR20000048767A/en not_active Application Discontinuation
- 1997-09-26 EE EEP199900135A patent/EE9900135A/en unknown
- 1997-09-26 TR TR1999/00634T patent/TR199900634T2/en unknown
- 1997-09-26 CA CA002266510A patent/CA2266510A1/en not_active Abandoned
- 1997-09-26 AU AU44638/97A patent/AU722147B2/en not_active Ceased
- 1997-09-26 JP JP10516272A patent/JP2001501217A/en active Pending
- 1997-09-26 HU HU9904091A patent/HUP9904091A3/en unknown
- 1997-09-26 IL IL12890297A patent/IL128902A/en not_active IP Right Cessation
- 1997-09-26 BR BR9711842A patent/BR9711842A/en not_active Application Discontinuation
- 1997-09-26 PL PL97332648A patent/PL332648A1/en unknown
- 1997-09-26 CN CN97198112A patent/CN1230959A/en active Pending
- 1997-09-26 CO CO97056315A patent/CO4650030A1/en unknown
- 1997-09-26 CZ CZ991126A patent/CZ112699A3/en unknown
- 1997-09-26 EP EP97943001A patent/EP0929550A1/en not_active Ceased
- 1997-09-26 SK SK422-99A patent/SK42299A3/en unknown
- 1997-09-26 WO PCT/FR1997/001692 patent/WO1998014444A1/en not_active Application Discontinuation
- 1997-09-26 NZ NZ334553A patent/NZ334553A/en unknown
- 1997-09-30 AR ARP970104493A patent/AR009105A1/en not_active Application Discontinuation
- 1997-09-30 TW TW086114229A patent/TW438800B/en active
- 1997-09-30 ZA ZA9708772A patent/ZA978772B/en unknown
-
1999
- 1999-03-22 BG BG103271A patent/BG103271A/en unknown
- 1999-03-30 NO NO991581A patent/NO991581L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EE9900135A (en) | 1999-12-15 |
| FR2753970A1 (en) | 1998-04-03 |
| AU4463897A (en) | 1998-04-24 |
| FR2753970B1 (en) | 1998-10-30 |
| NZ334553A (en) | 2000-11-24 |
| TR199900634T2 (en) | 1999-06-21 |
| IL128902A (en) | 2001-07-24 |
| IL128902A0 (en) | 2000-02-17 |
| CN1230959A (en) | 1999-10-06 |
| HUP9904091A2 (en) | 2000-05-28 |
| CA2266510A1 (en) | 1998-04-09 |
| SK42299A3 (en) | 1999-12-10 |
| AU722147B2 (en) | 2000-07-20 |
| BG103271A (en) | 2000-05-31 |
| AR009105A1 (en) | 2000-03-08 |
| HUP9904091A3 (en) | 2000-07-28 |
| BR9711842A (en) | 1999-08-24 |
| WO1998014444A1 (en) | 1998-04-09 |
| PL332648A1 (en) | 1999-09-27 |
| KR20000048767A (en) | 2000-07-25 |
| JP2001501217A (en) | 2001-01-30 |
| CO4650030A1 (en) | 1998-09-03 |
| NO991581D0 (en) | 1999-03-30 |
| EP0929550A1 (en) | 1999-07-21 |
| ZA978772B (en) | 1998-03-27 |
| TW438800B (en) | 2001-06-07 |
| CZ112699A3 (en) | 1999-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20075065L (en) | Use of isoflavone compounds to treat heart disease | |
| EA200000723A1 (en) | DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA | |
| TR200000595T2 (en) | 2,3-Diaryl-pyrazolo [1,5-B] pyridazines derivatives, their preparation and their use as inhibitors of cyclooxygenase 2 (COX-2). | |
| DK0977741T3 (en) | Substituted phenyl derivatives, their preparation and use | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| HUP0001192A2 (en) | The use of topiramate and its derivatives for the preparation of pharmaceutical compositions treating obesity | |
| HUP0101999A2 (en) | 4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them | |
| ZA200108126B (en) | Pharmaceutical compounds. | |
| HUP0400837A2 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
| TR200000059T2 (en) | Pyridine derivatives | |
| DE60121461D1 (en) | CONDENSED PYRIDOINDOL DERIVATIVES | |
| NO955326L (en) | Isoquinoline derivatives, process for their preparation and therapeutic use | |
| NO991581L (en) | N- (benzothiazol-2-yl) piperidine-1-ethanamine derivatives, their preparation and use in therapeutic agents | |
| FR2631625B1 (en) | PHENYL-6 DERIVATIVES PIPERAZINYLALKYL-3 1H, 3H-PYRIMIDINEDIONE-2,4, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION | |
| BR9913183A (en) | Compound, use of it, process to prepare it, process to treat a human or animal individual, and pharmaceutical composition | |
| NO172846C (en) | PROCEDURE FOR PREPARING 7,8-DIHALOGEN-3-METHYL-2,3-DIHYDRO-2M-BENZOCSAZINE DERIVATIVES AND PROPOXYBENZEN DERIVATIVES FOR EXERCISING THE PROCEDURE. | |
| DK192988A (en) | DIHYDROPYRIDINAMIDES, THEIR PREPARATION AND USE | |
| NO970573D0 (en) | Yliden compounds and their preparation | |
| ATE330958T1 (en) | PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES | |
| SE9603285D0 (en) | New compounds | |
| SE9404525D0 (en) | New uses of indolo- (3,2-b) -quinoxalines | |
| DK0607129T3 (en) | Methylpiperazinoazepine derivatives, their preparation and their use | |
| DK497888D0 (en) | N- (SUBSTITUTED ALKYLIDE) -1,2,3,4-TETRAHYDRO-9-A CRIDINAMINES, THEIR PREPARATION AND USE | |
| CA2142516A1 (en) | Stilbene-Based Materials, Their Preparation and Use | |
| NO890158D0 (en) | PROCEDURE FOR THE PREPARATION OF HYDROXIAL COOLING AGENT, THE ACQUIRED AGENTS AND THEIR USE. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |